» Articles » PMID: 31045528

A Novel Analytical Method of TFMPP and MCPP in Fluids of Drug Addicts Using LLE-GC/NPD

Overview
Publisher Sage Publications
Date 2019 May 3
PMID 31045528
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, drug-abuse problem is growing by leaps and bounds all over the world. The master minds spearheading its proliferation among the youth are difficult to identify, so drug-abuse case has become a hard nut to crack even with the help of best international experts in forensic science and criminology. Because most nations have tightened their controls on traditional drugs, the younger generation is now hooked onto new-type drugs: 1-(3- trifluoromethylphenyl) piperazine (TFMPP), 1-(3-chlorophenyl) piperazine (mCPP) and other new piperazine-drugs, acting as hallucinogens like 'ecstasy', are being consumed by vulnerable masses all over the world. However, only few research studies have focused on developing highly effective detection methods for TFMPP and mCPP in biological fluids; the number of detection methods for these new-type drugs is almost nil in China. Therefore, it is difficult to detect and prevent drug abuse cases related to piperazine drugs in China. There is an urgent need to develop some simple, fast, and reliable methods for detecting piperazine-drugs in vulnerable masses. Thus, the development of novel detection methods with high sensitivity and selectivity is a difficult task for the officials working in the department of forensic science in China. In this work, a new method was developed for the detection of piperazine derivatives: it was performed under the various specific conditions required for conducting chromatography and mass spectrometry analysis. With this novel method, TFMPP and mCPP was successfully detected with high accuracy in various biological samples. By comparing the purification effect of different solid-phase extraction columns for TFMPP and mCPP in biological fluids (urine and blood), we confirmed the validity of the novel method. In addition, this method has good linear relationship and a low detection line when GC/MS was performed for detecting TFMPP, mCPP in the biological fluids (urine and blood). It is a simple, reproducible method that is highly specific in the detection of piperazine-drugs. Thus, it is indeed a reliable method in forensic science.

Citing Articles

Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs.

Welz A, Koba M, Koslinski P, Siodmiak J J Clin Med. 2022; 11(7).

PMID: 35407366 PMC: 8999770. DOI: 10.3390/jcm11071758.


Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs.

Welz A, Koba M, Koslinski P, Siodmiak J J Clin Med. 2021; 10(24).

PMID: 34945109 PMC: 8704057. DOI: 10.3390/jcm10245813.

References
1.
Maurer H . Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review. Comb Chem High Throughput Screen. 2000; 3(6):467-80. DOI: 10.2174/1386207003331355. View

2.
Staack R, Fritschi G, Maurer H . Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 773(1):35-46. DOI: 10.1016/s1570-0232(01)00619-5. View

3.
Peters F, Schaefer S, Staack R, Kraemer T, Maurer H . Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom. 2003; 38(6):659-76. DOI: 10.1002/jms.483. View

4.
Staack R, Fritschi G, Maurer H . New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine. J Mass Spectrom. 2003; 38(9):971-81. DOI: 10.1002/jms.513. View

5.
Tancer M, Johanson C . Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug Alcohol Depend. 2003; 72(1):33-44. DOI: 10.1016/s0376-8716(03)00172-8. View